BDTX EPS Estimates
Black Diamond Therapeutics, Inc.
$1.70
+$0.02(+1.19%)
43
Overall
80
Value
10
Tech
39
Quality
Market Cap
$97.67M
Volume
1.07M
52W Range
$1.60 - $4.94
Target Price
$9.06
BDTX EPS estimates: the consensus estimate for Black Diamond Therapeutics, Inc.'s current fiscal year is -$0.57 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
BDTX EPS Estimates
- EPS estimate, current quarter
- $-0.03
- EPS estimate, next quarter
- $-0.22
- EPS estimate, current year
- $-0.57
- EPS estimate, next year
- $-1.03
- EPS growth, 3-year
- +29.16%
| Fiscal year | EPS |
|---|---|
| 2025 | $0.39 |
| 2024 | $-1.27 |
| 2023 | $-1.88 |
| 2022 | $-2.52 |
| 2021 | $-3.47 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BDTX | $1.70 | +1.2% | 1.07M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Black Diamond Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW